Gerresheimer stock weighs Q2 recovery against debt reduction

Published on 10/04/2026 at 15:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Gerresheimer stock saw adjusted EBITDA reach EUR 102 million in Q2 2026 on September 30, up EUR 35 million from Q1. The Centor sale adds debt reduction to the recovery story.

Isometrische Grafik der Wertschöpfungskette der Pharmaglasherstellung — Gerresheimer AG, ISIN DE000A0LD6E6, veranschaulicht in isometrischer Grafik die gesamte Wertschöpfungskette der Pharmaglasherstellung übersichtlich, Illustration mit AI erstellt.

Gerresheimer stock (ISIN DE000A0LD6E6) was last at EUR 27.52 on Xetra on October 2, 2026, at 5:35 p.m. CEST, with a daily change of minus 0.72 percent. The company paired its Q2 recovery with a completed Centor disposal as it works to reduce debt.

Q2 EBITDA reaches EUR 102 million

According to Deutsche Boerse on September 30, 2026, preliminary Q2 revenue reached EUR 578 million, up EUR 55 million from Q1. Adjusted EBITDA rose by EUR 35 million to EUR 102 million, more than 50 percent above the prior quarter.

The comparison with the prior year remains demanding. Q2 revenue was EUR 36 million below the EUR 614 million reported for Q2 2025, while adjusted EBITDA was EUR 24 million below the EUR 126 million prior-year figure. The adjusted EBITDA margin nevertheless reached 17.6 percent in Q2, 5.0 percentage points above Q1.

Centor proceeds target debt reduction

EQS Group reported on October 1, 2026, that Gerresheimer completed the sale of its US subsidiary Centor to a fund advised by Apax Partners. The combined enterprise value for Centor and the Primary Packaging Plastics business is EUR 1.5 billion, with Centor representing half of that amount.

The proceeds from the completed transaction are designated for debt reduction. The Primary Packaging Plastics disposal is expected to close in the first half of 2027, followed by a planned group refinancing and a more focused portfolio centered on primary packaging and drug delivery systems.

Jefferies keeps a cautious target

According to dpa-AFX on September 30, 2026, Jefferies kept Gerresheimer at Hold with a EUR 26.80 price target after the preliminary quarterly figures. The analyst cited the sequential EBITDA improvement but also pointed to higher net debt and lower liquidity.

Stock remains below yearly high

Gerresheimer stock was last at EUR 27.52 on Xetra on October 2, 2026, while its 52-week range was EUR 14.83 to EUR 38.32. The share price therefore stood 28.18 percent below the yearly high, leaving the debt reduction plan and the second-half recovery as the central valuation questions.